openPR Logo
Press release

What Are the Key Opportunities and Trends Shaping the Future of the Global Over-The-Counter (OTC) Pet Medication Market (2024-2033)?

Tailoring And Alteration Services Market Size

Tailoring And Alteration Services Market Size

The over-the-counter (OTC) pet medication market report describes and explains the over-the-counter (OTC) pet medication market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global over-the-counter (OTC) pet medication market reached a value of nearly $8,240.00 million in 2023, having grown at a compound annual growth rate (CAGR) of 2.94% since 2018. The market is expected to grow from $8,240.00 million in 2023 to $10,873.30 million in 2028 at a rate of 5.70%. The market is then expected to grow at a CAGR of 6.20% from 2028 and reach $14,689.37 million in 2033.

What are the upcoming opportunities in the global over-the-counter (OTC) pet medication market?
The key players in the market are adopting extensive strategies in the over-the-counter (OTC) pet medication market such as:
• Strengthen business capabilities through the launch of new drugs in the OTC pet medication market.
• Enhance business capabilities by pursuing strategic acquisitions to expand resources and expertise.
• Expand business operations through new product launches aimed at addressing evolving customer needs in the pet care market.
• Strengthen business operations by pursuing new business expansion initiatives to enter new markets or broaden product offerings.

Get The Complete Scope Of The Report
https://www.thebusinessresearchcompany.com/report/over-the-counter-otc-pet-medication-global-market-report

To take advantage of the opportunities, The Business Research Company recommends the over-the-counter (OTC) pet medication companies to focus on:
• Expand pet pharmacies to improve access to pet medications and veterinary services, ensuring greater availability for pet owners.
• Focus on strategic partnerships and acquisitions among major players to enhance product offerings and strengthen market position.

What is over-the-counter (OTC) pet medication: market definition?
Over-the-counter (OTC) pet medication (OTC pet medication) refers to pharmaceutical and healthcare products that are sold directly to pet owners without requiring a prescription. These medications address a wide variety of health concerns in pets, ranging from flea and tick control to nutritional supplements and pain relief.
The main medication types of over-the-counter (OTC) pet medication are flea and tick control, wormers and dewormers, dental care, nutritional supplements, skin and coat care, pain and allergy relief, and other medications. Flea and tick control products help to prevent and eliminate infestations of fleas and ticks on pets. These products can include topical treatments, collars, sprays, and oral medications that protect pets from these common parasites. The various pets include dogs, cats, birds, fishes and reptiles, and other pets and various forms include chews and treats, capsules and ointment, sprays, and other forms and supplied through various distribution channels such as drug and pharmacy stores, pet specialty stores, veterinary clinics and hospitals, online retailers, and other distribution channels.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report
https://www.thebusinessresearchcompany.com/sample_request?id=16499&type=smp

Who are the major companies operating in the global over-the-counter (OTC) pet medication market?
The global over-the-counter (OTC) pet medication market is highly concentrated, with large players operating in the market. The top ten competitors in the market made up to 50.39% of the total market in 2023. Zoetis Inc was the largest competitor with a 12.84% share of the market, followed by:
• Arab Pesticides and Veterinary Drugs Manufacturing Company (Mobedco-Vet)
• Ceva Santé Animale
• Boehringer Ingelheim International GmbH
• PetIQ, LLC
• Virbac
• Vetoquinol
• Bayer AG
• Merck & Co., Inc. (Merck Animal Health)
• Animalcare Group with 0.79%.

We Offer Customized Report, Click Here
https://www.thebusinessresearchcompany.com/Customise?id=16499&type=smp

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (https://www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release What Are the Key Opportunities and Trends Shaping the Future of the Global Over-The-Counter (OTC) Pet Medication Market (2024-2033)? here

News-ID: 3728273 • Views:

More Releases from The Business research company

Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Surgical Meshes Market Landscape to 2034: Key Forces Shaping the Next Decade of …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Surgical Meshes Market Size By 2025? In the past few years, the market size of surgical meshes has seen significant growth. It is projected to expand from $2.03 billion in 2024 to $2.18 billion in 2025, indicating a Compound Annual Growth Rate (CAGR) of 7.3%.
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accelerating Growth Trends
Rehabilitation Equipment Market Poised to Hit $23.97 Billion by 2029 with Accele …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Rehabilitation Equipment Market Size Growth Forecast: What to Expect by 2025? In recent times, there has been a significant growth in the size of the rehabilitation equipment market. Projected to increase from $17.36 billion in 2024, it is expected to reach $18.49 billion in 2025, with a compound annual
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast to 2034
Future of the Pediatric Neurology Device Market: Strategic Analysis and Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Pediatric Neurology Device Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for pediatric neurology devices has seen significant expansion in recent years, climbing from $2.5 billion in 2024 to an anticipated $2.65 billion in 2025, reflecting a compound annual growth rate (CAGR)
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: Innovative Products Boosting Profitability in the Orthokeratology Lens Market
Key Trends Influencing the Growth of the Orthokeratology Lens Market in 2025: In …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Orthokeratology Lens Market Through 2025? The market for orthokeratology lenses has seen a significant increase in size over recent years. It's projected to expand from $2.56 billion in 2024 to $2.75 billion in 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for OTC

Lawsuit filed for Investors who lost money with shares of adidas AG (OTC: ADDYY, …
An investor, who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), filed a lawsuit over alleged violations of Federal Securities Laws by adidas AG in connection with certain allegedly false and misleading statements. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and for certain investors are short and strict deadlines running. Deadline: June 27, 2023. adidas AG (OTC: ADDYY, OTC: ADDDF) investors should contact
Investigation for Investors in adidas AG (OTC: ADDYY, OTC: ADDDF) announced over …
An investigation on behalf of investors in shares of adidas AG (OTC: ADDYY, OTC: ADDDF) was announced over potential breaches of fiduciary duties by certain officers and directors at adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain adidas AG officers and
AMERICAN HEMP VENTURES INC (OTC: AMHV) TO BECOME YOUNEEQAI TECHNICAL SERVICES In …
FOR IMMEDIATE RELEASE Denver Colorado, March 31, 2023, American Hemp Ventures, Inc. (OTC: AMHV) announced today that its name has changed effective immediately to YouneeqAI Technical Services inc. (OTC: YQAI) reflecting the Company's new focus into cookie-less AI technology services. The current management team has over 50 years of experience in technology services and innovation. Murray Galbraith, YQAI's CEO, is the Founder of YouneeqAI's software solution and has operated several private technology
Investigation announced for Investors who lost money with shares of adidas AG (O …
An investigation was announced for investors of adidas AG (OTC: ADDYY, OTC: ADDDF) shares over potential securities laws violations by adidas AG. Investors who purchased shares of adidas AG (OTC: ADDYY, OTC: ADDDF), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of adidas AG (OTC: ADDYY,
Fuel Cell Market Technological Trends and Business Opportunities 2021 To 2026; P …
MarketInsightsReports has published a report titled global Fuel Cell Market research report 2021 that is a detailed observation of several aspects, including the rate of growth, technological advances, and different methodologies implemented by the primary current market players. The report is based on a collective analysis of data, which is obtained through primary and secondary research. It provides a systematic approach to the current and prospective scenario of this market. The
Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. According to